The Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) annual conference returned for its 21st year on Wednesday 17th and Thursday 18th May 2023. The event brings together healthcare professionals (HCPs) from Europe but also across the globe to share and discuss best treatment practice in the field of opioid dependence.
The two-day live virtual and interactive conference covered expert management and the latest published evidence within clinical areas of harm reduction, viral hepatitis, chronic and acute pain management. Two complex case discussions provided delegates the opportunity to bring their local practice challenges to an expert panel for discussion and debate.
All sessions at IOTOD 2023 were available in English, German and Spanish languages. The agenda included 7 educational sessions with presentations from 15 international experts, 2 sponsored satellite sessions and 5 scientific posters featuring the latest research and findings in the field of opioid dependence.
All live sessions were made available on-demand for 30 days post event, to enable delegates to access sessions they may have missed at their convenience.
Learner feedback has been exemplary on all fronts - the content quality and relevance to practice, the virtual experience, and overall event delivery.
“Great first day of the conference”
“Great speakers and content”
“IOTOD 2023 opening session has been great. Look forward to the other sessions and a great conference”
Following our evaluation survey, 95% of the attendees rated the quality of the content presented as excellent/good, 97.5% rated speakers as excellent/good, 97.5% rated the organised of the event as excellent/good and 100% said that there was no bias during the educational programme.
Marketing of the live and on-demand content took place through Cogora’s media channels and IOTOD’s own community of primary and secondary care healthcare professionals, gaining huge visibility for the activity. Key delegates include addiction specialists, GPs, primary care nurses, nurse prescribers, community pharmacists, psychiatrists, psychologists, as well as other healthcare professionals interested in the management of opioid use disorder, predominantly across Europe and the UK.